 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today announced that the Aesthetic Surgery Journal has published the...

Evolus Announces Publication of Safety and Duration Data from Phase 2 Study for Extra-Strength 40U Formulation of Jeuveau

Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today reported the grant of non-qualified stock options to purchase an...

Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Evolus, Inc. (NASDAQ:EOLS - Get Free Report) shares gapped down before the market opened on Wednesday . The stock had previously closed at $13.76, but opened at $13.36. Evolus shares last traded at...

Evolus (NASDAQ:EOLS) Shares Gap Down to $13.76

This is a signal that EOLS's price trend could be reversing, and it may be an opportunity to buy the stock or explore call options...

Evolus (EOLS, $14) Stochastic Oscillator left the oversold zone on March 27, 2024

Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio, today announced that members of its management team will present at the following investor...

Evolus to Participate in the 23rd Annual Needham Virtual Healthcare Conference

Evolus (EOLS, $13.8) Stochastic Oscillator left the oversold zone on March 25, 2024

Evolus, Inc. (NASDAQ:EOLS  Get Free Report) CFO Sandra Beaver sold 5,672 shares of Evolus stock in a transaction dated Tuesday, March 19th. The shares were sold at an average price of $13.92...

Sandra Beaver Sells 5,672 Shares of Evolus, Inc. (NASDAQ:EOLS) Stock

Evolus: Smooth Progress As Management Targets $700m Aesthetics Franchise Revenues By 2028...

Evolus: Smooth Progress As Management Targets $700m Aesthetics Franchise Revenues By 2028

This indicator may be signaling that EOLS's price has further to drop, since it moved below its price 14 days ago. Traders may consider selling the stock, shorting the stock, or exploring put options...

Evolus (EOLS, $13.99) entered Downtrend as Momentum indicator drops below 0 level on Mar 11, 2024

Evolus prices stock offering to raise about $50M...

Evolus prices stock offering to raise about $50M

Evolus, Inc. is a medical aesthetics company, which engages in the provision of medical aesthetic treatments and procedures. It offers products under the brand of Jeuveau. The company was founded by Scott Cannizzaro in November 2012 and is headquartered in Newport Beach, CA.

Volume (M)	84,567.00
52-Wk High	$15.43
52-Wk Low	$7.07

EOLS Evolus Inc

About

Feed

News

Sentiment

Earnings

Fundamentals